MetLife (MET)
(Delayed Data from NYSE)
$74.34 USD
+0.49 (0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$74.34 USD
+0.49 (0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Zacks News
Here's Why MetLife (MET) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Why MetLife (MET) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MetLife (MET) Q2 Earnings Beat on Favorable Underwriting Results
by Zacks Equity Research
MetLife's (MET) second-quarter 2024 results benefit from improved variable investment income, strong volumes and strength in the Group Benefits segment. However, poor performance in the RIS segment partially offset the results.
Here's What Key Metrics Tell Us About MetLife (MET) Q2 Earnings
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 7.04% and 2.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Q2 Beat or Miss: What's Ahead for These 5 Insurance Stocks?
by Kaibalya Pravo Dey
Improving business environment, underwriting practices and other factors are expected to have benefited insurance players in the second quarter. MET, AFL, AIG, ALL and EG will release earnings on Jul 31.
Can MetLife (MET) Tackle Lower Premiums in Q2 Earnings?
by Zacks Equity Research
MetLife's (MET) Q2 results are likely to benefit from growing net investment income and a well-performing Latin America segment, partly offset by a fall in overall premiums.
Stay Ahead of the Game With MetLife (MET) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of MetLife (MET) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
MetLife (MET) Arm MIM Secures $1.2B for 2nd Private Equity Fund
by Zacks Equity Research
MetLife (MET) Arm, MIM, plans to utilize $250 million on new private equity opportunities.
MetLife (MET), GeoBlue Unveil Globaline for Expatriate Benefits
by Zacks Equity Research
MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.
MetLife (MET), Micruity Unite to Enhance Retirement Solutions
by Zacks Equity Research
MetLife (MET) expands collaboration with Micruity in a bid to develop MetLife's Universal Digital Platform and enhance access to retirement solutions.
MetLife (MET) Unit to Manage 3M's $2.5B Pension Obligations
by Zacks Equity Research
MetLife's (MET) unit, Metropolitan Tower Life, is set to take over around $2.5 billion in defined benefit pension obligations from 3M, ensuring continued monthly payments to nearly 23,000 retirees.
Zacks Industry Outlook MetLife, American International, Prudential Financial, The Hartford Financial and Old Republic International
by Zacks Equity Research
MetLife, American International, Prudential Financial, The Hartford Financial and Old Republic International have been highlighted in this Industry Outlook article.
5 Multiline Insurers to Watch Amid Rising Insurance Demand
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and interest rate rise are expected to aid multiline insurers like MET, AIG, PRU, HIG and ORI.
MetLife (MET) Explores Acquisition of Hayfin Capital Management (revised)
by Zacks Equity Research
MetLife (MET) is in talks to consider the Hayfin Capital Management acquisition, expanding its presence in the private capital market.
MetLife (MET) Explores Acquisition of Hayfin Capital Management
by Zacks Equity Research
MetLife (MET) is in talks to consider the Hayfin Capital Management acquisition, expanding its presence in the private capital market.
Why Is MetLife (MET) Up 1.2% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MetLife's (MET) My Leave Navigator to Boost Leave Experience
by Zacks Equity Research
MetLife (MET) is introducing tailored products according to the market demand, enabling better market penetration and generating steady premiums.
Here's How Insurance ETFs Are Placed Post Q1 Earnings
by Sweta Killa
The decent earnings reports have helped the sector to survive the market rout seen last month.
MetLife (MET) Q1 Earnings Meet, Rise Y/Y on Lower Expenses
by Zacks Equity Research
MetLife's (MET) first-quarter results benefit from improved variable investment income. However, poor performance in the Group Benefits segment partially offset the results.
MetLife (MET) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MetLife (MET) Q1 Earnings Match Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 0% and 3.81%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?